COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
FDA Clears Expanded Access Program for HPC Therapy in Patients With Long COVID
February 04, 2026
FDA Implements Quality Management System Regulation for Medical Devices
February 04, 2026
Australia to Expand Individual Donor Assessment to Blood Donation in April
February 03, 2026